About
Recognized leader with over 25 years' experience in biostatistics, clinical development, and personalized medicine. Instrumental in Oncotype Dx development and founder of multiple clinical diagnostics companies, with current focus on early detection technologies for breast, prostate, lung, and colon cancer.
Experience
- Optina DiagnosticsAdvisorcurrent2025 — present
- DigitalDx VenturesEntrepreneur in Residencecurrent2024 — presentMenlo Park, California, United States
- CellMax LifeSr. VP Clinical Studies and Biostatisticscurrent2018 — presentSunnyvale, California
- Cellworks LifeChief Biostatistician and Clinical Studiescurrent2019 — presentSouth San Francisco, California, United States
- Valar LabsAdvisorcurrent2023 — present
- BioAIAdvisorcurrent2020 — present
- Multiple CompaniesBiostatistics and Clinical Developmentcurrent2016 — presentLos Altos, CA
- Delphi Diagnostics Inc.Advisor2023 — 2024
- Nephrosant, Inc.Founder2016 — 2019San Francisco Bay Area
- InvitaeBiostatistics & Clinical Studies2015 — 2016458 Brannan Street, San Francisco, CA 94107
- Genomic HealthSr. VP Biostatistics, Data Mgmt & Medical Operations2003 — 2015301 Penobscot Drive Redwood City, CA 94063-4700
- Novation BiosciencesFounder & CEO2001 — 2003Purchased by Agilent Technologies
- Incyte GenomicsGeneral Manager1997 — 2001Now Incyte Pharmaceuticals - 1801 Augustine Cut-off, Willmington, DE 19803
- Chiron CorporationAssociate Director Non-Clinical Statistics1994 — 1997Acquired by Novartis Pharmaceuticals
- Syntex PharmaceuticalsStatistician1988 — 1990Acquired by Roche Pharmaceuticals
Skills & more
Biostatistics26Genomics27Biotechnology20Bioinformatics12Statistics11Life Sciences17Clinical Trials7Pharmaceutical Industry6Lifesciences5Clinical Development7Oncology8Genetics4
+12 more
Molecular BiologyMedical DevicesRDrug DiscoveryData ManagementFDACancerData MiningqPCRInfectious DiseasesSASImmunologyFrom Drew's professional profile.
Colleagues at AOA Dx
Abby McElhinny
Chief Scientific Officer at AOA Dx
Alex Fisher
Chief Operating Officer & Co-Founder at AOA Dx
Anna Jeter
Chief Regulatory Officer & Co-Founder at AOA Dx
Cory Bystrom
Senior Director, Biomarker & Analytical Development at AOA Dx
Elizabeth Yarber
Senior Director of Clinical Operations at AOA Dx
Emily Chang
Director, R&D at AOA Dx
James White
Scientific Advisor at AOA Dx
John Friedman
Board Member at AOA Dx
Frequently asked questions
- Who is Drew Watson?
- Recognized leader with over 25 years' experience in biostatistics, clinical development, and personalized medicine. Instrumental in Oncotype Dx development and founder of multiple clinical diagnostics companies, with current focus on early detection technologies for breast, prostate, lung, and colon cancer.
- Where does Drew Watson work?
- Drew Watson is Clinical Advisor at AOA Dx.
- Where did Drew Watson go to school?
- Drew Watson studied at UCLA (Ph.D., Biostatistics); Stanford University (MS, Computational Statistics); California State University - East Bay (BS, Statistics).
Same school
Also attended UCLA499
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General Catalyst
+ 493 more
Also attended Stanford University2,000
Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital
+ 1,994 more
Also attended California State University - East Bay28
Shinta YuliaVice President, Finance at Sapphire VenturesSusan LeongClient Team Member at Generation Investment ManagementMie TamakiExecutive Assistant at Samsung Catalyst FundJessExecutive Assistant at Renegade PartnersSamantha PriceTalent Partner at AudaciousMichelle SerpaOffice Manager at UpWest
+ 22 more
Also attended Golden Gate University33
David PhuController at Felicis VenturesKate MitchellFounder at Scale Venture PartnersChristine SamsAssistant Controller at Crosslink CapitalSamantha ChoPartner, Accounting at Lux CapitalLaura TseVP of Finance at ParadigmKandi CraddockInvestor at Notable Capital
+ 27 more
Shared employers
Also worked at Optina Diagnostics4
Also worked at Nephrosant, Inc.2
Also worked at Invitae8
Shan YangVice President at Joyance PartnersEli CasdinChief Investment Officer and Founder at Casdin CapitalChitra NayakVenture Partner & Advisor at 1414 VenturesKyle LefkoffGeneral Partner at Boulder VenturesNick GreenfieldFounder at One CodexGuy SnirFounder/COO at Clear Genetics
+ 2 more
